- Dr. Judy Garber comments on a U.S. Preventive Services Task Force recommendation that women at high risk for breast cancer consider taking drugs to prevent the disease.
Tags: BreastCancer, Prevention
- Dr. Beth Overmoyer said women with Inflammatory Breast Cancer are often initially misdiagnosed because most doctors are not familiar with the disease.
- A study in the journal Cancer suggests that breast cancer patients who opt for lumpectomies with radiation might have a small survival advantage compared with those who have mastectomies. Dr. Mehra Golshan says it is hard to imagine that less surgery with radiation gives a better outcome.
Tags: BreastCancer, Radiation
- Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.
Tags: LungCancer, Genetics
- A study by Dr. Susan Dale Block found that the less money spent on medical care at the end of a person’s life resulted in a better death experience.
- Dana-Farber President and CEO Dr. Edward J. Benz, Jr., discussed the ongoing war on cancer and where the promising research is now
Tags: BasicResearch, Prevention
- In a recent national study led by Dr. Jane Weeks, 69 percent of those with stage 4 lung cancer and 81 percent of those with stage 4 colon cancer failed to understand that chemotherapy was not at all likely to cure their cancer.
Tags: chemotherapy, EndOfLife
- Nine factors explain some of the variance in the quality of life of patients with advanced cancer in end-of-life care, according to a study led by Dr. Holly Prigerson and associates at Dana-Farber and published in the Archives of Internal Medicine.
Showing 1-10 of 358 items